Cambridge Investment Research Advisors’s PROSHARES TR II ULTRASHORT BLOOMBERG COMMODITY CMD Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-8,340	Closed	-$377K	–	1740
2016 Q1	$377K	Sell	8,340 -3,333	-29%	-$169K	0.01%	1052
2015 Q4	$548K	Sell	11,673 -4,551	-28%	-$195K	0.01%	819
2015 Q3	$619K	Buy	16,224 +972	+6%	+$35.9K	0.02%	664
2015 Q2	$439K	Sell	15,252 -2,607	-15%	-$78.6K	0.01%	872
2015 Q1	$585K	Sell	17,859 -3,396	-16%	-$103K	0.02%	717
2014 Q4	$620K	Buy	+21,255	New	+$526K	0.02%	670

Other funds holding CMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cambridge Investment Research Advisors's CMD Position: Q2 2016 in Review

Cambridge Investment Research Advisors sold out of PROSHARES TR II ULTRASHORT BLOOMBERG COMMODITY (CMD) in Q2 2016, closing a stake of 8,340 shares — an estimated $377K sold.

Cambridge Investment Research Advisors first reported a position in CMD in Q4 2014 and held it in 6 quarters. The position peaked at $620K in Q4 2014. 4 funds tracked by Wall St. Rank hold CMD as of Q2 2016.

Cambridge Investment Research Advisors reported no remaining PROSHARES TR II ULTRASHORT BLOOMBERG COMMODITY position as of Q2 2016 after selling out during the quarter.
Cambridge Investment Research Advisors sold 8,340 PROSHARES TR II ULTRASHORT BLOOMBERG COMMODITY shares in Q2 2016, an estimated $377K.
Cambridge Investment Research Advisors first reported a position in PROSHARES TR II ULTRASHORT BLOOMBERG COMMODITY in Q4 2014 and held it in 6 quarters.
Cambridge Investment Research Advisors's PROSHARES TR II ULTRASHORT BLOOMBERG COMMODITY position peaked at $620K in Q4 2014.
4 funds tracked by Wall St. Rank held PROSHARES TR II ULTRASHORT BLOOMBERG COMMODITY as of Q2 2016.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2016, filed 4 Aug 2016.